The percentage of the target population vaccinated with a WHO-prequalified Diphtheria Tetanus Toxoid and Pertussis vaccine, reflecting immunization efforts and population immunity.

The percentage of the target population vaccinated with a WHO-prequalified Diphtheria Tetanus Toxoid and Pertussis vaccine, reflecting immunization efforts and population immunity.

The percentage of the target population vaccinated with a WHO-prequalified Measles Containing Vaccines (MCV) vaccine, reflecting immunization efforts and population immunity.

The percentage of the target population vaccinated with a WHO-prequalified Measles Containing Vaccines (MCV) vaccine, reflecting immunization efforts and population immunity.

The percentage of the target population vaccinated with a WHO-prequalified Oral Polio Vaccine (OPV) vaccine, reflecting immunization efforts and population immunity.

The percentage of the target population vaccinated with a WHO-prequalified Oral Polio Vaccine (OPV) vaccine, reflecting immunization efforts and population immunity.

The percentage of the target population vaccinated with a WHO-prequalified Pneumococcal Conjugate Vaccination (PCV) vaccine, reflecting immunization efforts and population immunity.

The percentage of the target population vaccinated with a WHO-prequalified Pneumococcal Conjugate Vaccination (PCV) vaccine, reflecting immunization efforts and population immunity.

The percentage of the target population vaccinated with a WHO-prequalified Diphtheria Tetanus Toxoid and Pertussis vaccine, reflecting immunization efforts and population immunity.

The percentage of the target population vaccinated with a WHO-prequalified Measles Containing Vaccines (MCV) vaccine, reflecting immunization efforts and population immunity.

The percentage of the target population vaccinated with a WHO-prequalified Oral Polio Vaccine (OPV) vaccine, reflecting immunization efforts and population immunity.

The percentage of the target population vaccinated with a WHO-prequalified Pneumococcal Conjugate Vaccination (PCV) vaccine, reflecting immunization efforts and population immunity.

There is no description for this package

The proportion of children who have not received the first dose of Diphtheria Tetanus Toxoid and Pertussis vaccine, serving as a key indicator of immunization gaps and access to essential health services.

There is no description for this package

The proportion of children who have not received the first dose of Measles Containing Vaccines (MCV) vaccine, serving as a key indicator of immunization gaps and access to essential health services.

There is no description for this package

The proportion of children who have not received the first dose of MonoHepB at birth vaccine, serving as a key indicator of immunization gaps and access to essential health services.

There is no description for this package

There is no description for this package

The proportion of children who have not received the first dose of Pneumococcal Conjugate Vaccination (PCV) vaccine, serving as a key indicator of immunization gaps and access to essential health services.

There is no description for this package

Coverage of routine immunization antigens

The proportion of children who have not received the first dose of Rotavirus Vaccination (ROTA) vaccine, serving as a key indicator of immunization gaps and access to essential health services.

The proportion of children who have not received the first dose of RTS Malaria Vaccination (RTS S1 & S3) vaccine, serving as a key indicator of immunization gaps and access to essential health services.

There is no description for this package

For the reported yellow fever cases, their mortality outcomes, classified as alive, dead, or unknown are reported.

The proportion of children who have not received the first dose of Yellow Fever (YF) vaccine, serving as a key indicator of immunization gaps and access to essential health services.

This dataset provides the case fatality rate (CFR) for yellow fever, representing the proportion of confirmed cases that result in death. It serves as a key indicator for assessing disease severity and guiding public health interventions.

This dataset classifies confirmed yellow fever cases by their method of confirmation, including epidemiological linkage, clinical symptoms, and laboratory test results, aiding in disease surveillance, outbreak investigation, and public health response.

This dataset categorizes yellow fever cases into confirmed, suspected, and discarded, aiding in surveillance, outbreak response, and disease control efforts. Confirmed cases are those verified through laboratory testing or clinical diagnosis, suspected cases involve individuals with symptoms awaiting confirmation, and discarded cases are those initially suspected but later ruled out.

This dataset tracks the collection and quality of specimens for yellow fever testing, evaluating factors such as timeliness, condition, and adequacy to ensure reliable diagnostic results.

This dataset reports the number of individuals vaccinated against yellow fever per 100,000 surviving infants, providing insights into immunization coverage and population protection levels.

The percentage of the target population vaccinated with a WHO-prequalified Bacille Calmette-Guerin (BCG) vaccine, reflecting immunization efforts and population immunity.

The proportion of children who have not received the first dose of Bacille Calmette-Guerin (BCG) vaccine, serving as a key indicator of immunization gaps and access to essential health services.

The percentage of the target population vaccinated with a WHO-prequalified Yellow Fever (YF) vaccine, reflecting immunization efforts and population immunity.